- TWD2.62bn
- TWD2.02bn
- TWD153.56m
- 28
- 13
- 36
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.34 | ||
| Price to Tang. Book | 1.39 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 16.65 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.72% | ||
| Return on Equity | -3.84% | ||
| Operating Margin | -104.31% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 91.81 | 168.94 | 135.47 | 162.49 | 153.56 | n/a | n/a | 9.97% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PhytoHealth Corporation is a Taiwan company principally engaged in the research, development and manufacture of new botanical drugs. The Company's main products include western medicines, Chinese herbal medicines, cosmetics, Class B drugs and supplementary food. The Company also provides pharmaceutical consulting services. The Company distributes its products in domestic market and to overseas markets.
Directors
- Yili Lee CHM
- Yiling Li VCH
- Yinshou Lin OTH
- Jingzhong Cai DRC
- Wenhua Chen DRC
- Wenzhi Huang DRC
- Zehong Huang DRC
- Yuru Lai DRC
- C.C. Lee DRC
- Bosen Wang DRC
- Mingfu Wang DRC
- Jinghui You DRC
- Shangui Lai IND
- Shuilong Lin IND
- T. S. Wang IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 24th, 1998
- Public Since
- May 7th, 2002
- No. of Employees
- 84
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Taiwan Stock Exchange- Shares in Issue
- 198,189,000
- Address
- 5F-1, No.167, Fu Hsing North Road, TAIPEI, 105
- Web
- https://www.phytohealth.com.tw/zh-Hant
- Phone
- +886 225453697
- Contact
- Yinshou Lin
- Auditors
- Ernst & Young
Upcoming Events for 4108
Similar to 4108
Adimmune
Taiwan Stock Exchange
Bora Pharmaceuticals Co
Taiwan Stock Exchange
BRIM Biotechnology
Taiwan Stock Exchange
Caliway Biopharmaceuticals Co
Taiwan Stock Exchange
Cenra
Taiwan Stock Exchange
FAQ
What is the Phytohealth share price?
As of Today at 22:38 UTC, shares in Phytohealth are trading at TWD12.90. This share price information is delayed by 15 minutes.
How has the Phytohealth share price performed this year?
Shares in Phytohealth last closed at TWD12.90 and the price had moved by -34.85% over the past 365 days. In terms of relative price strength the Phytohealth share price has underperformed the FTSE Developed Asia Pacific Index by -34.1% over the past year.
What are the analyst and broker recommendations for Phytohealth?
The overall consensus recommendation for Phytohealth is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Phytohealth dividend yield?
Phytohealth does not currently pay a dividend.
Does Phytohealth pay a dividend?
Phytohealth does not currently pay a dividend.
When does Phytohealth next pay dividends?
Phytohealth does not currently pay a dividend.
How do I buy Phytohealth shares?
To buy shares in Phytohealth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Phytohealth?
As of the previous close price of TWD12.90, shares in Phytohealth had a market capitalisation of TWD2.62bn.
Where are Phytohealth shares listed?
Here are the trading details for Phytohealth:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4108
What kind of share is Phytohealth?
Based on an overall assessment of its quality, value and momentum Phytohealth is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Phytohealth share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Phytohealth share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Phytohealth. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -22.55%.
As of the last closing price of TWD12.90, shares in Phytohealth were trading -24.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Phytohealth PE Ratio?
The Phytohealth PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD12.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Phytohealth?
Phytohealth's management team is headed by:
- Yili Lee - CHM
- Yiling Li - VCH
- Yinshou Lin - OTH
- Jingzhong Cai - DRC
- Wenhua Chen - DRC
- Wenzhi Huang - DRC
- Zehong Huang - DRC
- Yuru Lai - DRC
- C.C. Lee - DRC
- Bosen Wang - DRC
- Mingfu Wang - DRC
- Jinghui You - DRC
- Shangui Lai - IND
- Shuilong Lin - IND
- T. S. Wang - IND